Quality of life (QOL) after stroke is poorly characterized. We sought to determine long-term natural history and predictors of QOL among first ischemic stroke survivors without stroke recurrence or myocardial infarction (MI).
We sought, in a prospective, populationbased, multiethnic, urban stroke cohort study, to determine the long-term natural history and predictors of QOL among participants who experienced a first ischemic stroke. Our prior research provided evidence that disability increased over time after stroke independently of recurrence. 8 We hypothesized that ischemic stroke patients would similarly experience decline in QOL over 5 years independent of recurrent stroke and other risk factors. Since validated stroke-specific QOL scales were not available at the time of the design of this study, we used a validated generic QOL scale, the Spitzer QLI, 9 which has been used extensively in prior research in various diseases. [10] [11] [12] METHODS The Northern Manhattan Study (NOMAS) includes a population-based incident ischemic stroke follow-up study designed to determine predictors of stroke recurrence and prognosis in a multiethnic, urban population consisting of 63% Hispanic, 20% black, and 15% white residents. 13, 14 Selection of NOMAS cohort. Methods of patient identification and enrollment have been described. 15, 16 Briefly, patients were enrolled if they were 1) diagnosed with a first ischemic stroke, 2) age Ն40 years, and 3) resident in Northern Manhattan for Ն3 months in a household with a telephone. Case ascertainment occurred between July 1993 and June 1997, and assessments were completed in August 2001. Over 80% of patients with acute ischemic stroke in northern Manhattan are hospitalized at Columbia University Medical Center (CUMC). Subjects hospitalized at other local hospitals were identified through active surveillance of admissions to those hospitals and through agreements with local physicians. Approximately 5% of incident ischemic stroke patients in northern Manhattan were not hospitalized but were also included. 13, 16 Evaluation of patients occurred at the hospital; those subjects either not hospitalized or hospitalized elsewhere were evaluated in the outpatient research clinic. Among participants not hospitalized at CUMC, only those with an initial evaluation and standardized neurologic examination within 20 days of first stroke were included in analyses involving the NIH Stroke Scale (NIHSS).
Standard protocol approvals, registrations, and patient consents.
The CUMC Institutional Review Board approved the study. All participants gave written informed consent directly or through a surrogate when appropriate.
Index evaluation of subjects. Data were collected through interviews of the participant (or proxy, among those who could not be interviewed) by trained research assistants in English or Spanish (depending on the participant's primary language), and physical and neurologic examinations were conducted by study neurologists, as previously described. 15, 16 Race-ethnicity was selfidentified. Standardized questions were adapted from the Behavioral Risk Factor Surveillance System 17 by the Centers for Disease Control and Prevention to identify the following: hypertension (HTN), diabetes mellitus (DM), hypercholesterolemia, peripheral vascular disease, TIA, cigarette smoking, and cardiac conditions such as myocardial infarction (MI), coronary artery disease (CAD), angina, congestive heart failure (CHF), atrial fibrillation, other arrhythmias, and valvular heart disease. HTN was defined as in prior publications, 15, 16 and DM was defined by fasting blood glucose level Ն126 mg/dL, self-report of DM, or insulin/oral hypoglycemic use. Presence or absence of urinary incontinence within 7-10 days of the index stroke was determined. Depressed mood in the week prior to stroke was assessed by a standardized questionnaire at enrollment. Physical activity was assessed using a questionnaire 18 adapted from the National Health Interview Survey of the National Center for Health Statistics, and classified as light-moderate and heavy, as previously described. 15 Alcohol consumption was assessed as in previous publications. 19 Stroke severity was assessed using the NIHSS score derived from a standardized neurologic examination, and was categorized as mild (NIHSS Ͻ6), moderate (NIHSS 6 -13), and severe (NIHSS Ն14). This categorization was based on previous analyses of stroke severity in relation to stroke outcome from our population and a clinical trial. 20, 21 Stroke diagnostic evaluation included computerized tomography, brain MRI, or both; ultrasound evaluation, MRI, or both; vascular imaging; and echocardiography as appropriate. A consensus of stroke neurologists assessed stroke subtype using modified Stroke Data Bank criteria and all available information, as described in previous publications. 22, 23 Stroke neurologists also determined brain side of index stroke, presence of aphasia, and parietal lobe dysfunction.
Follow-up and outcomes assessment. Follow-up evaluations were conducted at 6 months, 1 year, 1.5 years, and then annually to 5 years. Each evaluation was conducted at CUMC, by telephone, or, for patients unable or unwilling to come to CUMC, by an in-person home visit by a research staff member. Evaluations were conducted with the patient, family member, and caregiver if available. Information on vital status, QOL as measured by QLI, and intercurrent symptoms, illness, or hospitalization was collected. In-person assessments additionally included measurement of vital signs and physical and neurologic examination.
The QLI is a 10-point scale, with higher numbers denoting better QOL. The patient, family member, or health care provider rated the patient's QOL in 5 domains-activity, daily living, health, support, and outlook-assigning a score of 0, 1, or 2 in each domain. The QLI has previously been used in Spanishspeaking populations. 24 Of 2,526 total QLI assessments in this study, 75% were assessed from the subject directly, and 52% were assessed during in-person visits.
Functional status measured by the Barthel Index (BI) was determined at all follow-up assessments; previous research demonstrated the reliability of phone assessments of the BI. 25 Mini-Mental State Examination (MMSE) was performed at 1-year in-person assessments. 26 An ongoing surveillance system of admissions to CUMC and other local hospitals, described in a previous publication, 13 was also used to identify study participants who experienced a clinically evident recurrent stroke, MI, hospitalization, or death. When available, medical records were reviewed for all outcome events including death by a specially trained research assistant and adjudicated by study neurologists or cardiologists, as appropriate.
Statistical analyses. Statistical analyses were conducted using SAS version 9.1.3 (SAS Institute, Cary, NC). For descriptive purposes, means were calculated for continuous variables and proportions for categorical variables. Follow-up was censored at the time of death, clinically evident recurrent stroke, or MI because of the anticipated adverse effect of these events on QOL.
QLI was analyzed first as a continuous variable. We used generalized estimating equations (GEE) to assess the relationship between several predictor variables, including time of follow-up at regular intervals, with repeated measurements of QLI. GEE models provided parameter estimates (␤) and 95% confidence intervals (95% CI) for the association between predictors and QLI across 5 years of follow-up, after adjusting for baseline demographic (age, sex, race/ethnicity, education level, marital status, insurance status) and medical risk factors (HTN, coronary artery disease or MI, DM, smoking, physical activity, alcohol consumption), depressed mood, as well as relevant stroke charac-teristics (initial stroke severity, aphasia, parietal lobe dysfunction including neglect, side of stroke, and presence of urinary incontinence). As a working correlation structure we chose the exchangeable (intraclass) structure since it provided the best fit. Final multivariate models were constructed in a backward stepwise manner using those variables with p value Ͻ0. 10 . In a separate model, we additionally adjusted for functional status as a time-dependent covariate, using categories of functional independence (BI Ն95) and dependence (BI Ͻ95), as in our prior analysis. 8 Insurance status was characterized as Medicare/private insurance vs Medicaid/no insurance.
Subgroup analysis was conducted among those with BI Ն95 6 months after stroke to assess the course and predictors of QOL among those deemed recovered after the acute phase. Among this cohort, the effect of cognitive status was assessed by including the 1-year MMSE in the multivariate model. Preliminary graphs of QLI over time showed a decline for those with Medicaid/no insurance. Interaction between time of follow-up assessment and each variable in the final model (including insurance) was therefore included in multivariate models to assess whether change in QLI differed by insurance status. A separate analysis with only self-reported QLI scores was conducted to assess whether proxy responses produced any bias.
Time of follow-up assessment was analyzed as a continuous variable as well as a discrete variable (at 1-, 1.5-, 2-, 3-, 4-, and 5-year time points, with 0.5 year as reference). Analysis of discrete time points assumed that the time trend was a flexible step function allowed to change at each time point. A lack of linearity test was conducted that allowed the time trend to take any functional form; this test determined whether the fit of the model was significantly improved over the linear model.
In order to assess the change in each domain of the QLI over time, each of the 5 domains was analyzed in a separate multivariate model, with time treated as a continuous variable and adjusted as above. The odds of having a maximum score (2 vs 0 or 1) was calculated for each domain. Tests for interactions between time to follow-up and other covariates were performed.
RESULTS
There were 655 patients enrolled in the NOMAS stroke incidence and follow-up study. No follow-up data were available for participants who died within 6 months (n ϭ 83) and for those who died between 6 months and 1 year (n ϭ 14). QLI data were not collected for a further 9 participants. Twenty-four participants had recurrent stroke before first QLI assessment and were excluded. A total of 525 patients were thus available for analysis. During follow-up, 84 patients had recurrent stroke or MI, and there were 133 deaths. Table 1 lists baseline characteristics of the study population. The median QLI score at 6 months was 8 (interquartile range 6 -10).
There was an annual decline in QLI in an unadjusted regression model considering time to follow-up assessment as a continuous variable (Ϫ0.09 per year, 95% CI Ϫ0.15 to Ϫ0.04). When adjusted for demographic variables, the annual decline was similar (Ϫ0.09 per year, 95% CI Ϫ0.15 to Ϫ0.03), and did not change further when adjusted for demographic variables, medical risk factors, and When BI Ն95 was added to the model as a timedependent covariate, the extent of decline in QLI lessened slightly but remained significant (Ϫ0.07 per year, 95% CI Ϫ0.13 to Ϫ0.01). Other predictors remained, and BI Ն95 was also a predictor (1.63 per year, 95% CI 1.36 to 1.91).
In subgroup analyses among those who had BI Ն95 at 6 months (n ϭ 245), there was still a significant annual decline in QLI over follow-up, even after adjustment for MMSE (table 3) . Higher cognitive scores on the MMSE were associated with better QLI.
Changes in QLI over time differed by insurance status ( p for interaction ϭ 0.0017), with a decline in QLI over time for those with Medicaid/no insurance (Ϫ0.20 per year in a fully adjusted model, 95% CI Ϫ0.29 to Ϫ0.11), whereas there was no definite decline among those with Medicare/private insurance (0.001 per year, 95% CI Ϫ0.08 to 0.09). The only other 2-way interaction was between time to follow-up and age at stroke onset ( p ϭ 0.02). The figure depicts QLI stratified by insurance status, unadjusted for other risk factors. Results were similar when the final multivariate model was restricted to self-reported QLI scores (available in 75% of the cohort), indicating that proxy assessments did not produce bias.
We fitted a model with discrete time points, without assuming a particular functional form for the time trend. A significant difference in QLI was seen at 3 years (Ϫ0.29, 95% CI Ϫ0.53 to Ϫ0.05), 4 years (Ϫ0.37, 95% CI Ϫ0.63 to Ϫ0.12), and 5 years (Ϫ0.54, 95% CI Ϫ0.87 to Ϫ0.21), each compared to the 0.5-year timepoint. Nonsignificant differences were seen for time points earlier than 3 years. In the final regression model, time was treated as a continuous variable with linear form, since there was no evidence that an alternative model better fit the data (lack of linearity 2 test: df ϭ 4, p ϭ 0.12).
When domains of QLI were analyzed separately, domain scores in activity (OR 0.88 per year, 95% CI 0.82 to 0.95), daily living (OR 0.89 per year, 95% CI 0.83 to 0.96), and support (OR 0.88 per year, 95% CI 0.79 to 0.98) were associated with time of follow-up assessment, after adjusting for demographics, medical risk factors, and stroke characteristics. There were interactions between insurance status and time of follow-up assessment for activity ( p for interaction ϭ 0.02), daily living ( p for interaction ϭ 0.02), and outlook ( p for interaction ϭ 0.01).
DISCUSSION
In this large, prospective, populationbased, multiethnic study of first ischemic stroke patients with multiple follow-up assessments, there was a significant linear decline in QOL in the years fol- lowing stroke among survivors free of clinically evident recurrent stroke or MI. This decline in QOL appeared independent of activities of daily living independence and cognition and began to be apparent at 3 years of follow-up. Furthermore, the decline in QOL was seen exclusively among the uninsured and those with Medicaid, a state-administered insurance only available to low-income residents, 27 which has been associated with limited access to health care in New York state. 28 A decline in QOL after the acute phase of stroke recovery has been observed in prior hospital-based studies, 29 but these have been limited by small sample sizes, limited follow-up, the inclusion of hemorrhagic stroke, and selected samples of hospitalized patients. Few population-based studies have examined QOL after stroke. One examined 304 stroke patients and 234 caregivers and found that Short Form-36 scores declined between 4 months and 16 months after stroke. Our study included a larger sample and assessed QOL multiple times during a longer follow-up period, and hence is able to delineate the natural history and predictors of QOL over the long term in an unselected stroke cohort while adjusting for potential confounders including stroke severity, function, and cognition. Furthermore, we censored recurrent strokes and MI, allowing us to determine the long-term effect on QOL of a single, first ischemic stroke alone.
Few studies have shown an effect of socioeconomic indicators on QOL after stroke. 5, 6 In our pop-ulation, baseline demographic and risk factor profiles differed between the 2 insurance groups. However, even after adjusting for these variables, a significant decline in QOL was seen exclusively among the uninsured and those insured with Medicaid. This decline may be due to disparities in access to rehabilitative services, information about health, and ongoing management of risk factors and chronic conditions. 7 Prior research has demonstrated an association between limited access to health care and worse medication compliance. 30 Also, the progression of white matter changes over time is more pronounced in the setting of poor blood pressure control 31 and subclinical infarcts are common. 32 In the Northern Manhattan population, 18% of 892 participants free of clinical stroke had subclinical infarcts. 33 Silent infarcts have been associated with cognitive function, 34 and cerebral leukoaraiosis with QOL in previous studies. 35 Accumulation of additional subclinical infarcts and leukoariosis over time may therefore account for the decline in QOL over time after stroke, and this effect may be most prominent in those with limited access to health care resources. Finally, socioeconomic status has an impact on indicators that may mediate QOL, such as disability and handicap after stroke. 36 Since we did not assess for the use of rehabilitative services, the development of comorbidities during follow-up, the extent of risk factor control, medical compliance, and subclinical infarcts, further research is needed to clarify the role of these variables on long-term QOL.
Similar to our study, age, 1,4 mood or depression, 2 stroke severity, 5,6 urinary incontinence, 37 side of stroke, 38 and DM 1 were also predictors of QOL in previous studies. Decline in QOL was most prominent in the domains of activity, daily living, and support, which is consistent with prior findings in this population, 8 and suggests that decline in QOL may be associated with decline in functional and occupational status. The interaction between time and insurance status in the domain of outlook suggests that limited access to care may have an impact on one's sense of control in matters of health.
A limitation of this study is that the use of the generic QLI might have missed stroke-specific aspects of QOL. However, we observed a significant decline in QLI and found predictors of QOL that are in parallel with prior research in stroke patients, suggesting that the scale is sensitive to the QOL of stroke patients. Another limitation is the absence of data about whether participants were diagnosed with depression. In the absence of a formal diagnosis, we employed a question that assessed mood in the 2 weeks prior to stroke, which was posed to patients after their first stroke and thus may be subject to recall bias. Finally, although this study delineates the natural history of QOL after ischemic stroke, further study is needed in other populations, such as stroke-free individuals, to be able to compare stroke patients with other groups. Providers who care for poststroke patients may be able to identify those at higher risk for poorer QOL and provide more aggressive rehabilitative and social support interventions. Future research should be directed toward clarifying the relationship between time, aging, and QOL; comparing QOL over time in stroke patients and stroke-free individuals; assessing QOL with stroke-specific scales 39, 40 not available at the time of the design of this study; and clarifying the role of ongoing risk factor management in the longterm QOL of stroke patients. . Dr. Elkind serves as Resident and Fellow Section Editor for Neurology ® ; serves as a consultant to Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, GlaxoSmithKline, Jarvik Heart, Tethys Bioscience, Inc., and Daiichi-Sankyo; serves on speakers' bureaus for Boehringer-Ingelheim, Inc. and Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership; and receives research support from dia-Dexus, Inc., Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, and the NIH/NINDS [ R01 NS050724 (PI), NS048134 (PI), P50 NS049060 (Project PI), R37 NS029993 (Co-PI), R01 NS55809 (Co-I), and R01 NS062820 (Co-I)]; and has given expert testimony on behalf of Merck Serono (Vioxx ® litigation), Pfizer Inc. (Shiley valve and Celebrex ® /Bextra ® litigation), and Novartis (Zelnorm ® and stroke litigation).
